Search Results - "VINALS, Francesc"

Refine Results
  1. 1

    Mitochondrial Phosphoenolpyruvate Carboxykinase (PEPCK-M) Is a Pro-survival, Endoplasmic Reticulum (ER) Stress Response Gene Involved in Tumor Cell Adaptation to Nutrient Availability by Méndez-Lucas, Andrés, Hyroššová, Petra, Novellasdemunt, Laura, Viñals, Francesc, Perales, Jose C.

    Published in The Journal of biological chemistry (08-08-2014)
    “…Mitochondrial phosphoenolpyruvate carboxykinase (PEPCK-M), encoded by the nuclear PCK2 gene, links TCA cycle intermediates and glycolytic pools through the…”
    Get full text
    Journal Article
  2. 2

    SGK1 is a signalling hub that controls protein synthesis and proliferation in endothelial cells by Medina‐Jover, Ferran, Gendrau‐Sanclemente, Núria, Viñals, Francesc

    Published in FEBS letters (01-10-2020)
    “…BMP9 is a cytokine involved in the maturation phase of the angiogenic process that signals through its serine/threonine receptor ALK1 and its coreceptor…”
    Get full text
    Journal Article
  3. 3

    The TGFβ pathway stimulates ovarian cancer cell proliferation by increasing IGF1R levels by Alsina‐Sanchis, Elisenda, Figueras, Agnès, Lahiguera, Álvaro, Vidal, August, Casanovas, Oriol, Graupera, Mariona, Villanueva, Alberto, Viñals, Francesc

    Published in International journal of cancer (15-10-2016)
    “…In a search for new therapeutic targets for treating epithelial ovarian cancer, we analyzed the Transforming Growth Factor Beta (TGFβ) signaling pathway in…”
    Get full text
    Journal Article
  4. 4

    Metronomic chemotherapy following the maximum tolerated dose is an effective anti‐tumour therapy affecting angiogenesis, tumour dissemination and cancer stem cells by Vives, Marta, Ginestà, Mireia M., Gracova, Kristina, Graupera, Mariona, Casanovas, Oriol, Capellà, Gabriel, Serrano, Teresa, Laquente, Berta, Viñals, Francesc

    Published in International journal of cancer (15-11-2013)
    “…In this article, the effectiveness of a multi‐targeted chemo‐switch (C‐S) schedule that combines metronomic chemotherapy (MET) after treatment with the maximum…”
    Get full text
    Journal Article
  5. 5

    Therapeutic Benefit of Selective Inhibition of p110α PI3-Kinase in Pancreatic Neuroendocrine Tumors by Soler, Adriana, Figueiredo, Ana M, Castel, Pau, Martin, Laura, Monelli, Erika, Angulo-Urarte, Ana, Milà-Guasch, Maria, Viñals, Francesc, Baselga, Jose, Casanovas, Oriol, Graupera, Mariona

    Published in Clinical cancer research (01-12-2016)
    “…Mutations in the PI3K pathway occur in 16% of patients with pancreatic neuroendocrine tumors (PanNETs), which suggests that these tumors are an exciting…”
    Get full text
    Journal Article
  6. 6

    Inhibition of the p110α isoform of PI 3-kinase stimulates nonfunctional tumor angiogenesis by Soler, Adriana, Serra, Helena, Pearce, Wayne, Angulo, Ana, Guillermet-Guibert, Julie, Friedman, Lori S, Viñals, Francesc, Gerhardt, Holger, Casanovas, Oriol, Graupera, Mariona, Vanhaesebroeck, Bart

    Published in The Journal of experimental medicine (23-09-2013)
    “…Understanding the direct, tumor cell-intrinsic effects of PI 3-kinase (PI3K) has been a key focus of research to date. Here, we report that cancer…”
    Get full text
    Journal Article
  7. 7

    New genetic drivers in hemorrhagic hereditary telangiectasia by Cerdà, Pau, Castillo, Sandra D, Aguilera, Cinthia, Iriarte, Adriana, Rocamora, José Luis, Larrinaga, Ane M, Viñals, Francesc, Graupera, Mariona, Riera-Mestre, Antoni

    Published in European journal of internal medicine (01-01-2024)
    “…Hereditary hemorrhagic telangiectasia (HHT) is a rare vascular disease inherited in an autosomal dominant manner. Disease-causing variants in endoglin (ENG)…”
    Get full text
    Journal Article
  8. 8

    A Role for CXCR4 in Peritoneal and Hematogenous Ovarian Cancer Dissemination by Figueras, Agnès, Alsina-Sanchís, Elisenda, Lahiguera, Álvaro, Abreu, Manuel, Muinelo-Romay, Laura, Moreno-Bueno, Gema, Casanovas, Oriol, Graupera, Mariona, Matias-Guiu, Xavier, Vidal, August, Villanueva, Alberto, Viñals, Francesc

    Published in Molecular cancer therapeutics (01-02-2018)
    “…Epithelial ovarian cancer is characterized by a low recovery rate because the disease is typically diagnosed at an advanced stage, by which time most patients…”
    Get full text
    Journal Article
  9. 9
  10. 10

    Sertoli-secreted FGF-2 induces PFKFB4 isozyme expression in mouse spermatogenic cells by activation of the MEK/ERK/CREB pathway by Gómez, Marta, Manzano, Anna, Figueras, Agnes, Viñals, Francesc, Ventura, Francesc, Rosa, Jose Luis, Bartrons, Ramon, Navarro-Sabaté, Àurea

    “…Sertoli cells play a central role in the control and maintenance of spermatogenesis by secreting growth factors, in response to hormonal stimulation, that…”
    Get more information
    Journal Article
  11. 11

    The impact of KRAS mutations on VEGF-A production and tumour vascular network by Figueras, Agnès, Arbos, Maria Antonia, Quiles, Maria Teresa, Viñals, Francesc, Germà, Josep Ramón, Capellà, Gabriel

    Published in BMC cancer (18-03-2013)
    “…The malignant potential of tumour cells may be influenced by the molecular nature of KRAS mutations being codon 13 mutations less aggressive than codon 12…”
    Get full text
    Journal Article
  12. 12

    The pancreatic niche inhibits the effectiveness of sunitinib treatment of pancreatic cancer by Martínez-Bosch, Neus, Guerrero, Pedro Enrique, Moreno, Mireia, José, Anabel, Iglesias, Mar, Munné-Collado, Jessica, Anta, Héctor, Gibert, Joan, Orozco, Carlos Alberto, Vinaixa, Judith, Fillat, Cristina, Viñals, Francesc, Navarro, Pilar

    Published in Oncotarget (26-07-2016)
    “…Current treatments for pancreatic ductal adenocarcinoma (PDA) are ineffective, making this the 4th leading cause of cancer deaths. Sunitinib is a…”
    Get full text
    Journal Article
  13. 13

    Antiangiogenic Therapy Elicits Malignant Progression of Tumors to Increased Local Invasion and Distant Metastasis by Pàez-Ribes, Marta, Allen, Elizabeth, Hudock, James, Takeda, Takaaki, Okuyama, Hiroaki, Viñals, Francesc, Inoue, Masahiro, Bergers, Gabriele, Hanahan, Douglas, Casanovas, Oriol

    Published in Cancer cell (03-03-2009)
    “…Multiple angiogenesis inhibitors have been therapeutically validated in preclinical cancer models, and several in clinical trials. Here we report that…”
    Get full text
    Journal Article
  14. 14

    BMP-2 regulation of PTHrP and osteoclastogenic factors during osteoblast differentiation of C2C12 cells by Susperregui, Antonio R.G., Viñals, Francesc, Ho, Patricia W.M., Gillespie, Matthew T., Martin, T. John, Ventura, Francesc

    Published in Journal of cellular physiology (01-07-2008)
    “…Bone morphogenetic protein‐2 (BMP‐2) is strongly involved in the induction of osteoblast differentiation from mesenchymal cell precursors, as well as in…”
    Get full text
    Journal Article
  15. 15

    Myogenin Protein Stability Is Decreased by BMP-2 through a Mechanism Implicating Id1 by Viñals Canals, Francesc, Ventura Pujol, Francesc

    Published in The Journal of biological chemistry (29-10-2004)
    “…Bone morphogenetic protein-2 (BMP-2) induces a switch in differentiation of mesenchymal cells from the myogenic to the osteogenic lineage. Here we describe…”
    Get full text
    Journal Article
  16. 16
  17. 17
  18. 18
  19. 19
  20. 20